Aura Biosciences (AURA) Share-based Compensation (2020 - 2026)

Aura Biosciences has reported Share-based Compensation for 7 years, with the latest figure at $3.8 million in Q1 2026.

• For the quarter ending Q1 2026, Share-based Compensation rose 8.82% year-over-year to $3.8 million; the trailing twelve-month figure through Mar 2026 stood at $14.6 million (up 18.66% YoY), and the FY2025 full-year result was $14.3 million, up 22.14% from the prior year.
• Share-based Compensation for Q1 2026 stood at $3.8 million, up from $3.3 million in the prior quarter.
• The five-year high for Share-based Compensation was $3.8 million in Q2 2025, with the low at $1.3 million in Q2 2022.
• Historically, Share-based Compensation has averaged $2.6 million across 5 years, with a median of $2.8 million in 2024.
• Annual changes were most pronounced in 2022 — Share-based Compensation surged 761.62% — and 2026, when it climbed 8.82%.
• Aura Biosciences' Share-based Compensation stood at $1.8 million in 2022, then jumped by 43.5% to $2.6 million in 2023, then grew by 12.83% to $2.9 million in 2024, then advanced by 11.75% to $3.3 million in 2025, then grew by 16.51% to $3.8 million in 2026.
• The last three Share-based Compensation figures came in at $3.8 million (Q1 2026), $3.3 million (Q4 2025), and $3.7 million (Q3 2025), per Business Quant data.